Influence of the American ODAC statement upon Austrian prescription practice of bevacizumab in metastatic breast cancer Veröffentlicht vonadmin 28. Juli 2020 Preusser, M, Fulop, G, Berghoff, AS, Heinzl, H, Steger, GG, Greil, R, Zielinski, CC, Bartsch, R http://www.ncbi.nlm.nih.gov/pubmed/22744818